All In MedTech

Device Trial Radar · NCT04192591

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

166

Actual

Start

Jan 30, 2020

Primary completion

Feb 2038

Study completion Feb 2041

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Dec 10, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

Conditions

  • Lumbar Spinal Stenosis

Interventions

  • Superion™ IDS deviceDevice

    The Superion™ IDS is a minimally-invasive spinal implant that treats LSS symptoms by limiting extension at the symptomatic level that compresses the neural elements and is designed for percutaneous surgical placement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of success at the 24-month follow-up visitTime frame: 24-Months

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Coastal Research Institute, LLC

    Carlsbad, California

  • MarinHealth Spine Institute

    Larkspur, California

  • Vitamed Research

    Rancho Mirage, California

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.